Showing results (1941-1950 of 6,943) with videos related to
Sort By:
Pageof 695
Cancer Science|September 18, 2021
Lomustine and nimustine exert efficient antitumor effects against glioblastoma models with acquired temozolomide resistanceShun Yamamuro, Masamichi Takahashi, Kaishi Satomi, et al.Cancer Science|August 4, 2022
JNK pathway plays a critical role for expansion of human colorectal cancer in the context of BRG1 suppressionTakaaki Yoshikawa, Akihisa Fukuda, Mayuki Omatsu, et al.Cancer Science|August 8, 2022
Nonhematogenic circulating aneuploid cells confer inferior prognosis and therapeutic resistance in gliomasMingxiao Li, Faliang Gao, Xiaohui Ren, et al.Cancer Science|September 12, 2021
SCRUM-Japan GI-SCREEN and MONSTAR-SCREEN: Path to the realization of biomarker-guided precision oncology in advanced solid tumorsYoshiaki Nakamura, Takao Fujisawa, Hiroya Taniguchi, et al.Cancer Science|September 15, 2021
Liquid biopsy of cerebrospinal fluid for MYD88 L265P mutation is useful for diagnosis of central nervous system lymphomaYuki Yamagishi, Nobuyoshi Sasaki, Yoshiko Nakano, et al.Cancer Science|September 16, 2021
Curcumin analog GO-Y030 boosts the efficacy of anti-PD-1 cancer immunotherapyTakashi MaruYama, Shuhei Kobayashi, Hiroyuki Shibata, et al.Cancer Science|September 7, 2021
Alcohol consumption, tobacco smoking, and subsequent risk of renal cell carcinoma: The JPHC studyTetsuji Minami, Manami Inoue, Norie Sawada, et al.Cancer Science|May 27, 2015
Functional differences between wild-type and mutant-type BRCA1-associated protein 1 tumor suppressor against malignant mesothelioma cellsShuhei Hakiri, Hirotaka Osada, Futoshi Ishiguro, et al.Cancer Science|May 8, 2015
MT95-4, a fully humanized antibody raised against aminopeptidase N, reduces tumor progression in a mouse modelShin Akita, Noboru Hattori, Takeshi Masuda, et al.Cancer Science|May 19, 2015
Immune checkpoint blockade opens an avenue of cancer immunotherapy with a potent clinical efficacyKeishi Adachi, Koji TamadaPageof 695